561 filings
Page 4 of 29
8-K
NGNE
Neurogene Inc
22 Sep 23
Neoleukin Therapeutics Announces 1-for-5 Reverse Stock Split
8:03am
UPLOAD
NGNE
Neurogene Inc
18 Sep 23
Letter from SEC
12:00am
S-4
NGNE
Neurogene Inc
18 Aug 23
Registration of securities issued in business combination transactions
6:19pm
SC 13D/A
NGNE
Neurogene Inc
17 Aug 23
Neoleukin Therapeutics / BAKER BROS. ADVISORS ownership change
5:12pm
4
NGNE
Neurogene Inc
17 Aug 23
Neoleukin Therapeutics / JULIAN BAKER ownership change
5:08pm
4
NGNE
Neurogene Inc
14 Aug 23
Neoleukin Therapeutics / Sean Michael Smith ownership change
4:06pm
10-Q
2023 Q2
NGNE
Neurogene Inc
Quarterly report
10 Aug 23
4:13pm
SC 13D
Redmile Group, LLC
27 Jul 23
Neoleukin Therapeutics / Redmile ownership change
5:15pm
SC 13D/A
NGNE
Neurogene Inc
19 Jul 23
Neoleukin Therapeutics / BAKER BROS. ADVISORS ownership change
5:28pm
425
NGNE
Neurogene Inc
18 Jul 23
Business combination disclosure
4:02pm
425
NGNE
Neurogene Inc
18 Jul 23
Business combination disclosure
8:37am
8-K
NGNE
Neurogene Inc
18 Jul 23
Neurogene and Neoleukin Announce Definitive Merger Agreement
8:34am
4
Baker Bros. Advisors
12 Jun 23
Neoleukin Therapeutics / JULIAN BAKER ownership change
4:03pm
8-K
NGNE
Neurogene Inc
12 Jun 23
Submission of Matters to a Vote of Security Holders
12:57pm
4
NGNE
Neurogene Inc
9 Jun 23
Neoleukin Therapeutics / TODD E SIMPSON ownership change
4:28pm
4
NGNE
Neurogene Inc
9 Jun 23
Neoleukin Therapeutics / ROHAN PALEKAR ownership change
4:27pm
4
Noonberg Sarah B.
9 Jun 23
Neoleukin Therapeutics / Sarah B. Noonberg ownership change
4:26pm
4
Erin Lavelle
9 Jun 23
Neoleukin Therapeutics / Erin Lavelle ownership change
4:25pm
4
Martin Babler
9 Jun 23
Neoleukin Therapeutics / Martin Babler ownership change
4:24pm
10-Q
2023 Q1
NGNE
Neurogene Inc
Quarterly report
8 May 23
4:17pm